UM

Browse/Search Results:  1-2 of 2 Help

Selected(0)Clear Items/Page:    Sort:
Post-translational modification of KRAS: potential targets for cancer therapy Journal article
Acta Pharmacologica Sinica, 2020
Authors:  Wang,Wei hua;  Yuan,Tao;  Qian,Mei jia;  Yan,Fang jie;  Yang,Liu;  He,Qiao jun;  Yang,Bo;  Lu,Jin jian;  Zhu,Hong
Favorite |  | TC[WOS]:2 TC[Scopus]:1 | Submit date:2021/03/02
Acetylation  Cancer Therapy  Kras  Nitrosylation  Oncogene  Palmitoylation  Phosphorylation  Post-translational Modification  Postprenylation  Prenylation  Sumoylation  Ubiquitination  
Substantial protection against MPTP-associated Parkinson's neurotoxicity in vitro and in vivo by anti-cancer agent SU4312 via activation of MEF2D and inhibition of MAO-B Journal article
NEUROPHARMACOLOGY, 2017,Volume: 126,Page: 12-24
Authors:  Guo, Baojian;  Hu, Shengquan;  Zheng, Chengyou;  Wang, Hongyu;  Luo, Fangcheng;  Li, Haitao;  Cui, Wei;  Yang, Xifei;  Cui, Guozhen;  Mak, Shinghung;  Choi, Tony Chung-Lit;  Ma, Edmond Dik-Lung;  Wang, Yuqiang;  Lee, Simon Ming Yuen;  Zhang, Zaijun;  Han, Yifan
View | Adobe PDF | Favorite |  | TC[WOS]:13 TC[Scopus]:14 | Submit date:2018/10/31
Parkinson's disease  SU4312  Neuroprotection  Myocyte enhancer factor 2D  Monoamine oxidase-B